Blog
RSS FeedPosted by Michael Wonder on 05 Nov 2019
Talking with Tama, a sick toddler who can't access the drug he needs
5 November 2019 - "Hi!" a bright young voice says down the phone. ...
Posted by Michael Wonder on 05 Nov 2019
New leukaemia medicine means three new cancer drugs funded this year
4 November 2019 - PHARMAC will fund a new leukaemia medicine, which will improve the quality of life for roughly ...
Posted by Michael Wonder on 05 Nov 2019
PHARMAC funding new leukaemia medicine
4 November 2019 - New Zealanders with chronic lymphocytic leukaemia will have another medicine option available to help them live ...
Posted by Michael Wonder on 03 Nov 2019
Hundreds of Kiwis battling leukaemia given hope with funding of new drug
4 November 2019 - Hundreds of Kiwis battling leukaemia cancer have been given hope, with PHARMAC today announcing funding for ...
Posted by Michael Wonder on 03 Nov 2019
Tama is deteriorating fast. But the drug that can help him is too expensive.
31 October 2019 - Tama Hubbard has good days and bad days, just like any other 3-year-old child. ...
Posted by Michael Wonder on 01 Nov 2019
'Why won’t they help him?': 'Broken' mother pleads for PHARMAC funding for toddler's rare disorder
1 November 2019 - The mother of a young boy is pleading with PHARMAC to fund a drug that could ...
Posted by Michael Wonder on 01 Nov 2019
Feilding epilepsy sufferer feared increased seizures following PHARMAC's drug brand switch
1 November 2019 - An epilepsy sufferer is urging others with the condition to boycott the Government's change in anti-epileptic ...
Posted by Michael Wonder on 31 Oct 2019
New Zealand Pharmaceutical Schedule - 1 November 2019
1 November 2019 - The November 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2019
Proposal to widen access to rituximab and change the funded brand for all funded indications excluding rheumatoid arthritis
31 October 2019 - PHARMAC is seeking feedback on a proposal to make changes to the funded brand of rituximab, ...
Posted by Michael Wonder on 30 Oct 2019
Growing medicines waiting list an international disgrace
29 October 2019 - The lack of transparency over timeliness and funding processes means New Zealand has a waiting list ...
Posted by Michael Wonder on 28 Oct 2019
Epilepsy sufferers not happy with PHARMAC drug change
28 October 2019 - PHARMAC has replaced its epilepsy drug - but some patients and families aren't happy about it. ...
Posted by Michael Wonder on 25 Oct 2019
Proposal to award sole supply for apomorphine hydrochloride
25 October 2019 - PHARMAC is proposing to make changes to the funding of apomorphine hydrochloride, a medicine used to ...
Posted by Michael Wonder on 24 Oct 2019
Mother fears daughter's death linked to PHARMAC's epilepsy drug switch
25 October 2019 - A woman who fears her daughter's death is linked to a change in her epilepsy medicine is ...
Posted by Michael Wonder on 23 Oct 2019
'You can't ignore cost': PHARMAC bosses recognise drug-buying constraints, promise transparency
23 October 2019 - PHARMAC's chief executive Sarah Fitt is defending the drug-buying agency in the face of petitioners calling ...
Posted by Michael Wonder on 22 Oct 2019
Proposal to widen access to bortezomib for multiple myeloma and amyloidosis
22 October 2019 - PHARMAC is seeking feedback on the proposal to change the Special Authority criteria for bortezomib. ...